LifePoint Health Reports Second Quarter 2015 Results

Go back to LifePoint Health Reports Second Quarter 2015 Results

Mizuho Securities Cuts Price Target on LifePoint Health (LPNT) to $93 Following 2Q

August 3, 2015 7:43 AM EDT

Mizuho Securities reiterates a Buy rating on Lifepoint Holdings (NASDAQ: LPNT), and cut the price target to $93.00 (from $95.71), following its 2Q report. Analyst Sheryl Skolnick asked LPNT, is growth in inpatient admits really as crucial to the success of hospitals in the current... More

LifePoint Health (LPNT) Tops Q2 EPS by 1c; Guides FY15 Revenue Ahead of Expectations

July 31, 2015 7:04 AM EDT

LifePoint Health (NASDAQ: LPNT) reported Q2 EPS of $1.00, $0.01 better than the analyst estimate of $0.99. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.24 billion.

LifePoint Health sees FY2015 EPS of $3.75 - $4.06, versus the consensus of $4.00. LifePoint Health sees FY2015... More